Streetbeat News

Stock Prices

LAMR

Lamar Advertising (NASDAQ:LAMR) reported Q1 earnings of $0.76 per share, missing the consensus estimate of $0.81 by 6.17%, but saw a 2.7% increase from last year's earnings. Sales reached $498.15M, exceeding estimates by 1.49% and marking a 5.69% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

CGNX

Cognex reported Q1 2024 adjusted EPS of $0.11, surpassing the $0.08 estimate, with sales of $210.797M also beating the $200.419M forecast. This represents a 4.81% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

CI

Cigna Group (NYSE:CI) reported Q1 2024 adjusted EPS of $6.47, surpassing the $6.37 estimate, and sales of $57.255B, exceeding the $55.471B estimate. This represents a 19.59% increase in earnings and a 23.08% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

AUPH

Aurinia Pharmaceuticals reported Q1 2024 earnings with a GAAP EPS of $(0.07), surpassing the $(0.14) estimate. Sales reached $50.3M, exceeding the $47.453M forecast, marking a 46.18% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:01 am

UPWK

BTIG analyst Marvin Fong upgrades Upwork (NASDAQ:UPWK) from Neutral to Buy and sets a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:57 am

TSLA

Tesla, Inc. (NASDAQ:TSLA) is seeking shareholder reapproval for CEO Elon Musk's 2018 compensation plan, previously voided by a Delaware court. Environmental expert Eric Roesch criticized the plan as excessive, highlighting its disproportion to Tesla's financials. Tesla's revenue and net income have significantly grown, with the company aiming for a shareholder vote on the compensation package, now valued at $44.9 billion. The upcoming shareholder meeting is expected to be contentious due to recent stock performance and the magnitude of Musk's proposed payout.

Portfolio Pulse from Shanthi Rexaline

May 02, 2024 | 9:55 am

FSLR

Goldman Sachs analyst Brian Kinstlinger maintains a Buy rating on First Solar (NASDAQ:FSLR) and raises the price target from $265 to $268.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:52 am

CHT

Chunghwa Telecom (NYSE:CHT) reported a decrease in Q1 earnings per share to $0.39 from $0.41 YoY and a sales decline to $1.75B from $1.78B YoY, indicating a slight downturn in performance.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:51 am

MULN

Mullen Automotive, Inc. (NASDAQ:MULN) shares are experiencing an uptick in premarket trading on Thursday, following a significant drop of 21.9% in the previous session. The increase comes after the company announced a partnership with Pritchard EV to expand its U.S. dealer network, aiming to enhance its commercial EV lineup's reach across the country. This collaboration will allow Pritchard EV to offer Mullen's Commercial EV models, including the Mullen ONE and Mullen THREE, to customers nationwide. Additionally, Mullen highlighted the recent CARB certification for its 2025 Mullen THREE model, emphasizing the vehicle's readiness for delivery and the availability of incentives for electrifying commercial fleets.

Portfolio Pulse from Nabaparna Bhattacharya

May 02, 2024 | 9:50 am

CTLT

LLY

NVO

Novo Nordisk A/S (NVO) is experiencing a significant increase in U.S. patients starting on its weight-loss drug, Wegovy, despite facing supply constraints and competition from Eli Lilly & Co. (LLY). Wegovy sales more than doubled in the first quarter, reaching $1.35 billion, although this was below analysts' expectations. Novo Nordisk is doubling its manufacturing investment to $6.4 billion, not including an $11 billion acquisition of factories from Catalent Inc. (CTLT). The company is also expanding Wegovy's market to Japan and expects sales and operating profit to surge by up to 27% and 30%, respectively, this year. However, pricing pressures and regulatory challenges in the U.S. and Denmark are affecting the company.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 9:48 am